Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
about
Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulinInflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.Update on toll-like receptor-directed therapies for human diseaseDevelopments in lupus 2006Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's diseaseThe B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigensTargeting of the immune system in systemic lupus erythematosus.The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivoClassification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian Tamils.The Immunomodulatory Effect of Bone-Marrow Mesenchymal Stem Cells on Expression of TLR3 and TLR9 in Mice Dendritic CellsInhibitory short synthetic oligodeoxynucleotides and lupus.Toll-like receptors and innate immune responses in systemic lupus erythematosus.Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
P2860
Q34017633-8B38BB1C-4FB0-4F3B-9E57-F46F08983D0DQ34114826-63BCADD8-6D47-4660-8B5E-26190E0FA1B2Q34965726-E0E6C2F5-855C-417B-B4A8-B04ABD48CBFEQ35566819-C634ABD8-A65F-4609-9AE2-3B89A10E9B21Q36171745-CDD9C792-2322-40B1-BC0B-17DDFB60B1C7Q36392336-5A0D54E9-183F-4B66-A7D8-0A162D97FAFBQ36567230-B45F93A3-F458-4962-BAC1-5E0BA4936870Q36903244-092F6700-FD27-4916-A976-3952664C772AQ37012927-79B5E84C-35B9-4049-95A6-A6893CE0855AQ37060593-F49717FB-B8E8-4AE0-A6E7-16929A7346FAQ37062264-A37AC8F9-7B26-45A5-B1B3-4CEBA7E8674AQ37270799-57A8F2B0-E324-4F49-B721-BAC3556433CEQ37758263-9BA8CEA0-71C1-4C5E-AAC0-017EB67D7E1DQ37956536-109196E6-6686-4A13-A6F5-2C3CAD80866FQ38840219-E8F7DCCE-A033-4475-811A-FE23ECE97A63Q42316872-F00411C4-ECBE-4B62-9823-97F4B199A104Q42560878-24D37BC8-B0D7-4348-B496-94CE61EF42DCQ43049852-B14B7CA1-4AC2-4957-BC89-ABFB4A2A16CEQ49852055-698F967C-F895-4669-8C08-3203B83442ACQ49884872-DD206CB6-06B0-4494-B978-3144D69C3C8BQ51965126-96B4ABD8-5519-4DC1-BE0E-40AC67AF3EC4Q53314342-A23F68D5-1EE6-4464-A3BF-E9A1A3169ADE
P2860
Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@ast
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@en
type
label
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@ast
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@en
prefLabel
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@ast
Targeting Toll-like receptor s ...... cells as a therapy for lupus.
@en
P2860
P921
P356
P1476
Targeting Toll-like receptor s ...... B cells as a therapy for lupus
@en
P2093
Petar S Lenert
P2860
P2888
P356
10.1186/AR1888
P50
P577
2006-01-10T00:00:00Z
P5875
P6179
1014969674